CS
CELC icon

Credit Suisse’s Celcuity CELC Stock Holding History

Credit Suisse’s Portfolio CELC Stock Details CELC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed – – 4061
2022
Q2 		$0 Buy
+5
New +$37 ﹤0.01% 3966

Other funds holding CELC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Suisse's CELC Position: Q3 2022 in Review

Credit Suisse sold out of Celcuity (CELC) in Q3 2022, closing a stake of 5 shares.

Credit Suisse first reported a position in CELC in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 30 funds tracked by Wall St. Rank hold CELC as of Q3 2022.

  • Credit Suisse reported no remaining Celcuity position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 5 Celcuity shares in Q3 2022.
  • Credit Suisse first reported a position in Celcuity in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's Celcuity position peaked at $0 in Q2 2022.
  • 30 funds tracked by Wall St. Rank held Celcuity as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.